|
Columbia, Md. (October 29, 2012) – The Foundation Fighting Blindness, a national non-profit organization dedicated to sight-saving retinal research, has named Steven D. Alper, of Towaco, NJ, to its board of directors. As the world’s leading private funder of research for retinal degenerative diseases, the Foundation works to advance preventions, treatments and cures for people affected with retinitis pigmentosa (RP), macular degeneration, Usher syndrome and related conditions.
 |
|
Steve Alper (right) with fellow board
member Eddie Russnow at the
Foundation Fighting Blindness’
Fashion Ball: Dining in the Dark
event in May.
|
Alper, a managing director at Barclays Wealth and Investment Management, has been involved with the Foundation since 1997 and a national trustee of the organization since 2004. He and his wife Elyse have served on committees for successful Foundation Visionary Awards Dinners in New York City, as well as co-founded the New Jersey Taste for Sight and New Jersey Fantasy Hockey events. Also chair of the Foundation’s New York Metro Leadership Council and a member of the board’s development committee, Alper lends his business savvy and philanthropic drive to help the more than 10 million Americans affected by retinal diseases.
“Steve Alper has provided significant support for the Foundation’s work in a variety of ways,” says Bill Schmidt, CEO, Foundation Fighting Blindness. “We’re proud to appoint him to our board of passionate leaders whose ongoing collaboration and direction fuels our sight-saving research progress.
About Foundation Fighting Blindness
The Foundation Fighting Blindness is a national nonprofit driving research that will lead to preventions, treatments and cures for retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases that affect more than 10 million Americans. Since 1971, the Foundation has raised more than $450 million as the leading non-governmental funder of retinal research. Breakthrough Foundation-funded studies using gene therapy have restored significant vision in children and young adults who were previously blind, paving the way for using this method to treat a variety of retinal degenerative diseases, and proving a cure is in sight. With a network of nearly 50 chapters, the Foundation also provides support and resources to affected individuals and their families in communities across the country.
|
